A panel of experts explore the impact of sickle cell disease on patients and discuss treatment and management considerations.
February 18th 2022
An overview on the pathophysiology of sickle cell disease and expert perspectives on the clinical (and psychosocial) burden it presents.
Shared insight on how a patient’s life may progress following a diagnosis of sickle cell disease, along with considerations for pediatric versus adult management.
February 25th 2022
Expert panelists reflect on the global prevalence of sickle cell disease, as well as general disease awareness.
Expert perspectives on the importance of newborn screening to impact mortality rates in sickle cell disease.
March 4th 2022
Wally Smith, MD, and Payal Desai, MD, spearhead a discussion on patient education surrounding sickle cell disease symptomology and lifestyle modifications.
A broad perspective on the value of multimodality care in the management of patients diagnosed with sickle cell disease.
March 11th 2022
A focused discussion on how comprehensive care is applied by multidisciplinary teams to improve the management of sickle cell disease.
Reflections on optimal approaches to patient follow-up, particularly regarding pain management and inherent risks in high-dose opioids.
March 18th 2022
Focusing on disease-modifying therapeutics, expert panelists discuss foundational treatment goals and guidelines for sickle cell disease.
Expert perspectives on hydroxyurea as a staple therapy in the treatment armamentarium for sickle cell disease.
Noah Rindos, MD, Talks Fibroids, Adenomyosis and Pregnancy
Kausik Ray, MD: A Risk-Based Look at LDL Cholesterol Lowering
Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy